Global AI In Oncology Production, Demand and Key Producers, 2022-2028
The application of AI in cancer practice includes providing clinical decision support for cancer diagnosis and screening, processing medical data for cancer detection or characterization of patient prognosis, and optimizing care delivery and clinical operations by increasing system capacity and allocating resources.
This report studies the global AI In Oncology demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI In Oncology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI In Oncology that contribute to its increasing demand across many markets.
The global AI In Oncology market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global AI In Oncology total market, 2017-2028, (USD Million)
Global AI In Oncology total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: AI In Oncology total market, key domestic companies and share, (USD Million)
Global AI In Oncology revenue by player and market share 2017-2022, (USD Million)
Global AI In Oncology total market by Type, CAGR, 2017-2028, (USD Million)
Global AI In Oncology total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global AI In Oncology market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Azra AI, IBM, Siemens Healthineers, Intel, GE Healthcare, NVIDIA, Digital Diagnostics Inc., Concert.AI and Median Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI In Oncology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global AI In Oncology Market, By Region:
1. How big is the global AI In Oncology market?
2. What is the demand of the global AI In Oncology market?
3. What is the year over year growth of the global AI In Oncology market?
4. What is the total value of the global AI In Oncology market?
5. Who are the major players in the global AI In Oncology market?
6. What are the growth factors driving the market demand?
This report studies the global AI In Oncology demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI In Oncology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI In Oncology that contribute to its increasing demand across many markets.
The global AI In Oncology market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global AI In Oncology total market, 2017-2028, (USD Million)
Global AI In Oncology total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: AI In Oncology total market, key domestic companies and share, (USD Million)
Global AI In Oncology revenue by player and market share 2017-2022, (USD Million)
Global AI In Oncology total market by Type, CAGR, 2017-2028, (USD Million)
Global AI In Oncology total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global AI In Oncology market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Azra AI, IBM, Siemens Healthineers, Intel, GE Healthcare, NVIDIA, Digital Diagnostics Inc., Concert.AI and Median Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI In Oncology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global AI In Oncology Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Software Solutions
- Hardware
- Services
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Brain Tumor
- Others
- Azra AI
- IBM
- Siemens Healthineers
- Intel
- GE Healthcare
- NVIDIA
- Digital Diagnostics Inc.
- Concert.AI
- Median Technologies
- Path AI
1. How big is the global AI In Oncology market?
2. What is the demand of the global AI In Oncology market?
3. What is the year over year growth of the global AI In Oncology market?
4. What is the total value of the global AI In Oncology market?
5. Who are the major players in the global AI In Oncology market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 AI In Oncology Introduction
1.2 World AI In Oncology Market Size & Forecast (2017 & 2021 & 2028)
1.3 World AI In Oncology Total Market by Region
1.3.1 World AI In Oncology Market Size by Region (2017-2028)
1.3.2 United States AI In Oncology Market Size (2017-2028)
1.3.3 China AI In Oncology Market Size (2017-2028)
1.3.4 Europe AI In Oncology Market Size (2017-2028)
1.3.5 Japan AI In Oncology Market Size (2017-2028)
1.3.6 South Korea AI In Oncology Market Size (2017-2028)
1.3.7 ASEAN AI In Oncology Market Size (2017-2028)
1.3.8 India AI In Oncology Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI In Oncology Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AI In Oncology Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD AI IN ONCOLOGY COMPANIES COMPETITIVE ANALYSIS
2.1 World AI In Oncology Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global AI In Oncology Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for AI In Oncology in 2021
2.2.3 Global Concentration Ratios (CR8) for AI In Oncology in 2021
2.3 AI In Oncology Company Evaluation Quadrant
2.4 AI In Oncology Market: Overall Company Footprint Analysis
2.4.1 AI In Oncology Market: Region Footprint
2.4.2 AI In Oncology Market: Company Product Type Footprint
2.4.3 AI In Oncology Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: AI In Oncology Market Comparison
3.1.1 United States VS China: AI In Oncology Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: AI In Oncology Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States AI In Oncology Major Players and Market Share, 2017-2022
3.2.1 Major Players of AI In Oncology in United States, Headquarters (States, Country)
3.2.2 United States AI In Oncology Revenue by Domestic Player, (2017-2022)
3.3 China AI In Oncology Major Players and Market Share, 2017-2022
3.3.1 Major Players of AI In Oncology in China, Headquarters (Province, Country)
3.3.2 China AI In Oncology Revenue by Domestic Player, (2017-2022)
3.4 Rest of World AI In Oncology Major Players and Market Share, 2017-2022
3.4.1 Major Players of AI In Oncology in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World AI In Oncology Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World AI In Oncology Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Software Solutions
4.2.2 Hardware
4.2.3 Services
4.3 Market Segment by Type
4.3.1 World AI In Oncology Market Size by Type (2017-2022)
4.3.2 World AI In Oncology Market Size by Type (2023-2028)
4.3.3 World AI In Oncology Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World AI In Oncology Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Breast Cancer
5.2.2 Lung Cancer
5.2.3 Prostate Cancer
5.2.4 Colorectal Cancer
5.2.5 Colorectal Cancer
5.2.6 Others
5.3 Market Segment by Application
5.3.1 World AI In Oncology Market Size by Application (2017-2022)
5.3.2 World AI In Oncology Market Size by Application (2023-2028)
5.3.3 World AI In Oncology Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Azra AI
6.1.1 Azra AI Details
6.1.2 Azra AI Major Business
6.1.3 Azra AI AI In Oncology Product and Services
6.1.4 Azra AI AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Azra AI Recent Developments/Updates
6.1.6 Azra AI Competitive Strengths & Weaknesses
6.2 IBM
6.2.1 IBM Details
6.2.2 IBM Major Business
6.2.3 IBM AI In Oncology Product and Services
6.2.4 IBM AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 IBM Recent Developments/Updates
6.2.6 IBM Competitive Strengths & Weaknesses
6.3 Siemens Healthineers
6.3.1 Siemens Healthineers Details
6.3.2 Siemens Healthineers Major Business
6.3.3 Siemens Healthineers AI In Oncology Product and Services
6.3.4 Siemens Healthineers AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Siemens Healthineers Recent Developments/Updates
6.3.6 Siemens Healthineers Competitive Strengths & Weaknesses
6.4 Intel
6.4.1 Intel Details
6.4.2 Intel Major Business
6.4.3 Intel AI In Oncology Product and Services
6.4.4 Intel AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Intel Recent Developments/Updates
6.4.6 Intel Competitive Strengths & Weaknesses
6.5 GE Healthcare
6.5.1 GE Healthcare Details
6.5.2 GE Healthcare Major Business
6.5.3 GE Healthcare AI In Oncology Product and Services
6.5.4 GE Healthcare AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 GE Healthcare Recent Developments/Updates
6.5.6 GE Healthcare Competitive Strengths & Weaknesses
6.6 NVIDIA
6.6.1 NVIDIA Details
6.6.2 NVIDIA Major Business
6.6.3 NVIDIA AI In Oncology Product and Services
6.6.4 NVIDIA AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 NVIDIA Recent Developments/Updates
6.6.6 NVIDIA Competitive Strengths & Weaknesses
6.7 Digital Diagnostics Inc.
6.7.1 Digital Diagnostics Inc. Details
6.7.2 Digital Diagnostics Inc. Major Business
6.7.3 Digital Diagnostics Inc. AI In Oncology Product and Services
6.7.4 Digital Diagnostics Inc. AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Digital Diagnostics Inc. Recent Developments/Updates
6.7.6 Digital Diagnostics Inc. Competitive Strengths & Weaknesses
6.8 Concert.AI
6.8.1 Concert.AI Details
6.8.2 Concert.AI Major Business
6.8.3 Concert.AI AI In Oncology Product and Services
6.8.4 Concert.AI AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Concert.AI Recent Developments/Updates
6.8.6 Concert.AI Competitive Strengths & Weaknesses
6.9 Median Technologies
6.9.1 Median Technologies Details
6.9.2 Median Technologies Major Business
6.9.3 Median Technologies AI In Oncology Product and Services
6.9.4 Median Technologies AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Median Technologies Recent Developments/Updates
6.9.6 Median Technologies Competitive Strengths & Weaknesses
6.10 Path AI
6.10.1 Path AI Details
6.10.2 Path AI Major Business
6.10.3 Path AI AI In Oncology Product and Services
6.10.4 Path AI AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Path AI Recent Developments/Updates
6.10.6 Path AI Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of AI In Oncology and Key Manufacturers
7.2 AI In Oncology Manufacturing Costs
7.3 AI In Oncology Production Process
7.4 AI In Oncology Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for AI In Oncology Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 AI In Oncology Typical Distributors
8.3 AI In Oncology Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 AI In Oncology Introduction
1.2 World AI In Oncology Market Size & Forecast (2017 & 2021 & 2028)
1.3 World AI In Oncology Total Market by Region
1.3.1 World AI In Oncology Market Size by Region (2017-2028)
1.3.2 United States AI In Oncology Market Size (2017-2028)
1.3.3 China AI In Oncology Market Size (2017-2028)
1.3.4 Europe AI In Oncology Market Size (2017-2028)
1.3.5 Japan AI In Oncology Market Size (2017-2028)
1.3.6 South Korea AI In Oncology Market Size (2017-2028)
1.3.7 ASEAN AI In Oncology Market Size (2017-2028)
1.3.8 India AI In Oncology Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI In Oncology Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AI In Oncology Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD AI IN ONCOLOGY COMPANIES COMPETITIVE ANALYSIS
2.1 World AI In Oncology Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global AI In Oncology Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for AI In Oncology in 2021
2.2.3 Global Concentration Ratios (CR8) for AI In Oncology in 2021
2.3 AI In Oncology Company Evaluation Quadrant
2.4 AI In Oncology Market: Overall Company Footprint Analysis
2.4.1 AI In Oncology Market: Region Footprint
2.4.2 AI In Oncology Market: Company Product Type Footprint
2.4.3 AI In Oncology Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: AI In Oncology Market Comparison
3.1.1 United States VS China: AI In Oncology Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: AI In Oncology Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States AI In Oncology Major Players and Market Share, 2017-2022
3.2.1 Major Players of AI In Oncology in United States, Headquarters (States, Country)
3.2.2 United States AI In Oncology Revenue by Domestic Player, (2017-2022)
3.3 China AI In Oncology Major Players and Market Share, 2017-2022
3.3.1 Major Players of AI In Oncology in China, Headquarters (Province, Country)
3.3.2 China AI In Oncology Revenue by Domestic Player, (2017-2022)
3.4 Rest of World AI In Oncology Major Players and Market Share, 2017-2022
3.4.1 Major Players of AI In Oncology in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World AI In Oncology Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World AI In Oncology Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Software Solutions
4.2.2 Hardware
4.2.3 Services
4.3 Market Segment by Type
4.3.1 World AI In Oncology Market Size by Type (2017-2022)
4.3.2 World AI In Oncology Market Size by Type (2023-2028)
4.3.3 World AI In Oncology Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World AI In Oncology Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Breast Cancer
5.2.2 Lung Cancer
5.2.3 Prostate Cancer
5.2.4 Colorectal Cancer
5.2.5 Colorectal Cancer
5.2.6 Others
5.3 Market Segment by Application
5.3.1 World AI In Oncology Market Size by Application (2017-2022)
5.3.2 World AI In Oncology Market Size by Application (2023-2028)
5.3.3 World AI In Oncology Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Azra AI
6.1.1 Azra AI Details
6.1.2 Azra AI Major Business
6.1.3 Azra AI AI In Oncology Product and Services
6.1.4 Azra AI AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Azra AI Recent Developments/Updates
6.1.6 Azra AI Competitive Strengths & Weaknesses
6.2 IBM
6.2.1 IBM Details
6.2.2 IBM Major Business
6.2.3 IBM AI In Oncology Product and Services
6.2.4 IBM AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 IBM Recent Developments/Updates
6.2.6 IBM Competitive Strengths & Weaknesses
6.3 Siemens Healthineers
6.3.1 Siemens Healthineers Details
6.3.2 Siemens Healthineers Major Business
6.3.3 Siemens Healthineers AI In Oncology Product and Services
6.3.4 Siemens Healthineers AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Siemens Healthineers Recent Developments/Updates
6.3.6 Siemens Healthineers Competitive Strengths & Weaknesses
6.4 Intel
6.4.1 Intel Details
6.4.2 Intel Major Business
6.4.3 Intel AI In Oncology Product and Services
6.4.4 Intel AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Intel Recent Developments/Updates
6.4.6 Intel Competitive Strengths & Weaknesses
6.5 GE Healthcare
6.5.1 GE Healthcare Details
6.5.2 GE Healthcare Major Business
6.5.3 GE Healthcare AI In Oncology Product and Services
6.5.4 GE Healthcare AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 GE Healthcare Recent Developments/Updates
6.5.6 GE Healthcare Competitive Strengths & Weaknesses
6.6 NVIDIA
6.6.1 NVIDIA Details
6.6.2 NVIDIA Major Business
6.6.3 NVIDIA AI In Oncology Product and Services
6.6.4 NVIDIA AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 NVIDIA Recent Developments/Updates
6.6.6 NVIDIA Competitive Strengths & Weaknesses
6.7 Digital Diagnostics Inc.
6.7.1 Digital Diagnostics Inc. Details
6.7.2 Digital Diagnostics Inc. Major Business
6.7.3 Digital Diagnostics Inc. AI In Oncology Product and Services
6.7.4 Digital Diagnostics Inc. AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Digital Diagnostics Inc. Recent Developments/Updates
6.7.6 Digital Diagnostics Inc. Competitive Strengths & Weaknesses
6.8 Concert.AI
6.8.1 Concert.AI Details
6.8.2 Concert.AI Major Business
6.8.3 Concert.AI AI In Oncology Product and Services
6.8.4 Concert.AI AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Concert.AI Recent Developments/Updates
6.8.6 Concert.AI Competitive Strengths & Weaknesses
6.9 Median Technologies
6.9.1 Median Technologies Details
6.9.2 Median Technologies Major Business
6.9.3 Median Technologies AI In Oncology Product and Services
6.9.4 Median Technologies AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Median Technologies Recent Developments/Updates
6.9.6 Median Technologies Competitive Strengths & Weaknesses
6.10 Path AI
6.10.1 Path AI Details
6.10.2 Path AI Major Business
6.10.3 Path AI AI In Oncology Product and Services
6.10.4 Path AI AI In Oncology Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Path AI Recent Developments/Updates
6.10.6 Path AI Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of AI In Oncology and Key Manufacturers
7.2 AI In Oncology Manufacturing Costs
7.3 AI In Oncology Production Process
7.4 AI In Oncology Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for AI In Oncology Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 AI In Oncology Typical Distributors
8.3 AI In Oncology Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World AI In Oncology Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World AI In Oncology Market Size by Region (2017-2022) & (USD Million)
Table 3. World AI In Oncology Market Size by Region (2023-2028) & (USD Million)
Table 4. World AI In Oncology Market Size Market Share by Region (2017-2022)
Table 5. World AI In Oncology Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World AI In Oncology Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key AI In Oncology Players in 2021
Table 9. World AI In Oncology Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global AI In Oncology Company Evaluation Quadrant
Table 11. Head Office of Key AI In Oncology Player
Table 12. AI In Oncology Market: Company Product Type Footprint
Table 13. AI In Oncology Market: Company Product Application Footprint
Table 14. AI In Oncology Mergers & Acquisitions Activity
Table 15. United States VS China AI In Oncology Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of AI In Oncology in United States, Headquarters (States, Country)
Table 17. United States AI In Oncology Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States AI In Oncology Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of AI In Oncology in China, Company Headquarters (Province, Country)
Table 20. China AI In Oncology Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China AI In Oncology Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of AI In Oncology in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World AI In Oncology Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World AI In Oncology Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World AI In Oncology Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World AI In Oncology Revenue by Type (2017-2022) & (USD Million)
Table 27. World AI In Oncology Revenue by Type (2023-2028) & (USD Million)
Table 28. World AI In Oncology Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World AI In Oncology Revenue by Application (2017-2022) & (USD Million)
Table 30. World AI In Oncology Revenue by Application (2023-2028) & (USD Million)
Table 31. Azra AI Basic Information, Area Served and Competitors
Table 32. Azra AI Major Business
Table 33. Azra AI AI In Oncology Product and Services
Table 34. Azra AI AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Azra AI Recent Developments/Updates
Table 36. Azra AI Competitive Strengths & Weaknesses
Table 37. IBM Basic Information, Area Served and Competitors
Table 38. IBM Major Business
Table 39. IBM AI In Oncology Product and Services
Table 40. IBM AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. IBM Recent Developments/Updates
Table 42. IBM Competitive Strengths & Weaknesses
Table 43. Siemens Healthineers Basic Information, Area Served and Competitors
Table 44. Siemens Healthineers Major Business
Table 45. Siemens Healthineers AI In Oncology Product and Services
Table 46. Siemens Healthineers AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Siemens Healthineers Recent Developments/Updates
Table 48. Siemens Healthineers Competitive Strengths & Weaknesses
Table 49. Intel Basic Information, Area Served and Competitors
Table 50. Intel Major Business
Table 51. Intel AI In Oncology Product and Services
Table 52. Intel AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Intel Recent Developments/Updates
Table 54. Intel Competitive Strengths & Weaknesses
Table 55. GE Healthcare Basic Information, Area Served and Competitors
Table 56. GE Healthcare Major Business
Table 57. GE Healthcare AI In Oncology Product and Services
Table 58. GE Healthcare AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. GE Healthcare Recent Developments/Updates
Table 60. GE Healthcare Competitive Strengths & Weaknesses
Table 61. NVIDIA Basic Information, Area Served and Competitors
Table 62. NVIDIA Major Business
Table 63. NVIDIA AI In Oncology Product and Services
Table 64. NVIDIA AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. NVIDIA Recent Developments/Updates
Table 66. NVIDIA Competitive Strengths & Weaknesses
Table 67. Digital Diagnostics Inc. Basic Information, Area Served and Competitors
Table 68. Digital Diagnostics Inc. Major Business
Table 69. Digital Diagnostics Inc. AI In Oncology Product and Services
Table 70. Digital Diagnostics Inc. AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Digital Diagnostics Inc. Recent Developments/Updates
Table 72. Digital Diagnostics Inc. Competitive Strengths & Weaknesses
Table 73. Concert.AI Basic Information, Area Served and Competitors
Table 74. Concert.AI Major Business
Table 75. Concert.AI AI In Oncology Product and Services
Table 76. Concert.AI AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Concert.AI Recent Developments/Updates
Table 78. Concert.AI Competitive Strengths & Weaknesses
Table 79. Median Technologies Basic Information, Area Served and Competitors
Table 80. Median Technologies Major Business
Table 81. Median Technologies AI In Oncology Product and Services
Table 82. Median Technologies AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Median Technologies Recent Developments/Updates
Table 84. Path AI Basic Information, Area Served and Competitors
Table 85. Path AI Major Business
Table 86. Path AI AI In Oncology Product and Services
Table 87. Path AI AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 88. AI In Oncology Raw Material
Table 89. Key Manufacturers of AI In Oncology Raw Materials
Table 90. AI In Oncology Typical Distributors
Table 91. AI In Oncology Typical Customers
Table 1. World AI In Oncology Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World AI In Oncology Market Size by Region (2017-2022) & (USD Million)
Table 3. World AI In Oncology Market Size by Region (2023-2028) & (USD Million)
Table 4. World AI In Oncology Market Size Market Share by Region (2017-2022)
Table 5. World AI In Oncology Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World AI In Oncology Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key AI In Oncology Players in 2021
Table 9. World AI In Oncology Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global AI In Oncology Company Evaluation Quadrant
Table 11. Head Office of Key AI In Oncology Player
Table 12. AI In Oncology Market: Company Product Type Footprint
Table 13. AI In Oncology Market: Company Product Application Footprint
Table 14. AI In Oncology Mergers & Acquisitions Activity
Table 15. United States VS China AI In Oncology Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of AI In Oncology in United States, Headquarters (States, Country)
Table 17. United States AI In Oncology Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States AI In Oncology Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of AI In Oncology in China, Company Headquarters (Province, Country)
Table 20. China AI In Oncology Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China AI In Oncology Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of AI In Oncology in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World AI In Oncology Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World AI In Oncology Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World AI In Oncology Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World AI In Oncology Revenue by Type (2017-2022) & (USD Million)
Table 27. World AI In Oncology Revenue by Type (2023-2028) & (USD Million)
Table 28. World AI In Oncology Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World AI In Oncology Revenue by Application (2017-2022) & (USD Million)
Table 30. World AI In Oncology Revenue by Application (2023-2028) & (USD Million)
Table 31. Azra AI Basic Information, Area Served and Competitors
Table 32. Azra AI Major Business
Table 33. Azra AI AI In Oncology Product and Services
Table 34. Azra AI AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Azra AI Recent Developments/Updates
Table 36. Azra AI Competitive Strengths & Weaknesses
Table 37. IBM Basic Information, Area Served and Competitors
Table 38. IBM Major Business
Table 39. IBM AI In Oncology Product and Services
Table 40. IBM AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. IBM Recent Developments/Updates
Table 42. IBM Competitive Strengths & Weaknesses
Table 43. Siemens Healthineers Basic Information, Area Served and Competitors
Table 44. Siemens Healthineers Major Business
Table 45. Siemens Healthineers AI In Oncology Product and Services
Table 46. Siemens Healthineers AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Siemens Healthineers Recent Developments/Updates
Table 48. Siemens Healthineers Competitive Strengths & Weaknesses
Table 49. Intel Basic Information, Area Served and Competitors
Table 50. Intel Major Business
Table 51. Intel AI In Oncology Product and Services
Table 52. Intel AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Intel Recent Developments/Updates
Table 54. Intel Competitive Strengths & Weaknesses
Table 55. GE Healthcare Basic Information, Area Served and Competitors
Table 56. GE Healthcare Major Business
Table 57. GE Healthcare AI In Oncology Product and Services
Table 58. GE Healthcare AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. GE Healthcare Recent Developments/Updates
Table 60. GE Healthcare Competitive Strengths & Weaknesses
Table 61. NVIDIA Basic Information, Area Served and Competitors
Table 62. NVIDIA Major Business
Table 63. NVIDIA AI In Oncology Product and Services
Table 64. NVIDIA AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. NVIDIA Recent Developments/Updates
Table 66. NVIDIA Competitive Strengths & Weaknesses
Table 67. Digital Diagnostics Inc. Basic Information, Area Served and Competitors
Table 68. Digital Diagnostics Inc. Major Business
Table 69. Digital Diagnostics Inc. AI In Oncology Product and Services
Table 70. Digital Diagnostics Inc. AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Digital Diagnostics Inc. Recent Developments/Updates
Table 72. Digital Diagnostics Inc. Competitive Strengths & Weaknesses
Table 73. Concert.AI Basic Information, Area Served and Competitors
Table 74. Concert.AI Major Business
Table 75. Concert.AI AI In Oncology Product and Services
Table 76. Concert.AI AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Concert.AI Recent Developments/Updates
Table 78. Concert.AI Competitive Strengths & Weaknesses
Table 79. Median Technologies Basic Information, Area Served and Competitors
Table 80. Median Technologies Major Business
Table 81. Median Technologies AI In Oncology Product and Services
Table 82. Median Technologies AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Median Technologies Recent Developments/Updates
Table 84. Path AI Basic Information, Area Served and Competitors
Table 85. Path AI Major Business
Table 86. Path AI AI In Oncology Product and Services
Table 87. Path AI AI In Oncology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 88. AI In Oncology Raw Material
Table 89. Key Manufacturers of AI In Oncology Raw Materials
Table 90. AI In Oncology Typical Distributors
Table 91. AI In Oncology Typical Customers
LIST OF FIGURES
Figure 1. AI In Oncology Picture
Figure 2. World AI In Oncology Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World AI In Oncology Total Market Size (2017-2028) & (USD Million)
Figure 4. World AI In Oncology Market Size Market Share by Region (2017-2028)
Figure 5. United States AI In Oncology Market Size (2017-2028) & (USD Million)
Figure 6. China AI In Oncology Market Size (2017-2028) & (USD Million)
Figure 7. Europe AI In Oncology Market Size (2017-2028) & (USD Million)
Figure 8. Japan AI In Oncology Market Size (2017-2028) & (USD Million)
Figure 9. South Korea AI In Oncology Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN AI In Oncology Market Size (2017-2028) & (USD Million)
Figure 11. India AI In Oncology Market Size (2017-2028) & (USD Million)
Figure 12. AI In Oncology Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of AI In Oncology by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for AI In Oncology Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for AI In Oncology Markets in 2021
Figure 17. United States VS China: AI In Oncology Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World AI In Oncology Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World AI In Oncology Market Size Market Share by Type in 2021
Figure 20. Software Solutions
Figure 21. Hardware
Figure 22. Services
Figure 23. World AI In Oncology Market Size Market Share by Type (2017-2028)
Figure 24. World AI In Oncology Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 25. World AI In Oncology Market Size Market Share by Application in 2021
Figure 26. Breast Cancer
Figure 27. Lung Cancer
Figure 28. Prostate Cancer
Figure 29. Colorectal Cancer
Figure 30. Brain Tumor
Figure 31. Others
Figure 32. World AI In Oncology Market Size Market Share by Application (2017-2028)
Figure 33. Manufacturing Cost Structure Analysis of AI In Oncology in 2021
Figure 34. Manufacturing Process Analysis of AI In Oncology
Figure 35. AI In Oncology Industrial Chain
Figure 36. Distribution Channel Breakdown for AI In Oncology Shipments (%): 2017-2028
Figure 37. Direct Channel Pros & Cons
Figure 38. Indirect Channel Pros & Cons
Figure 39. Methodology
Figure 40. Research Process and Data Source
Figure 1. AI In Oncology Picture
Figure 2. World AI In Oncology Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World AI In Oncology Total Market Size (2017-2028) & (USD Million)
Figure 4. World AI In Oncology Market Size Market Share by Region (2017-2028)
Figure 5. United States AI In Oncology Market Size (2017-2028) & (USD Million)
Figure 6. China AI In Oncology Market Size (2017-2028) & (USD Million)
Figure 7. Europe AI In Oncology Market Size (2017-2028) & (USD Million)
Figure 8. Japan AI In Oncology Market Size (2017-2028) & (USD Million)
Figure 9. South Korea AI In Oncology Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN AI In Oncology Market Size (2017-2028) & (USD Million)
Figure 11. India AI In Oncology Market Size (2017-2028) & (USD Million)
Figure 12. AI In Oncology Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of AI In Oncology by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for AI In Oncology Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for AI In Oncology Markets in 2021
Figure 17. United States VS China: AI In Oncology Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World AI In Oncology Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World AI In Oncology Market Size Market Share by Type in 2021
Figure 20. Software Solutions
Figure 21. Hardware
Figure 22. Services
Figure 23. World AI In Oncology Market Size Market Share by Type (2017-2028)
Figure 24. World AI In Oncology Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 25. World AI In Oncology Market Size Market Share by Application in 2021
Figure 26. Breast Cancer
Figure 27. Lung Cancer
Figure 28. Prostate Cancer
Figure 29. Colorectal Cancer
Figure 30. Brain Tumor
Figure 31. Others
Figure 32. World AI In Oncology Market Size Market Share by Application (2017-2028)
Figure 33. Manufacturing Cost Structure Analysis of AI In Oncology in 2021
Figure 34. Manufacturing Process Analysis of AI In Oncology
Figure 35. AI In Oncology Industrial Chain
Figure 36. Distribution Channel Breakdown for AI In Oncology Shipments (%): 2017-2028
Figure 37. Direct Channel Pros & Cons
Figure 38. Indirect Channel Pros & Cons
Figure 39. Methodology
Figure 40. Research Process and Data Source
